Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
Camurus proclaims constructive Part 3 outcomes from the ACROINNOVA 2 examine of octreotide SC depot (CAM2029) in acromegaly sufferers By Investing.com
Therapy nicely tolerated with a security profile in line with standard-of-care (SoC)Elevated…
